The FDA granted priority review for belzutifan for treating advanced pheochromocytoma and paraganglioma, with a PDUFA date set for May 26, 2025.
The FDA has accepted a priority review sNDA for Welireg in adults and pediatric patients with advanced or metastatic pheochromocytoma and paraganglioma.
According to the Centers for Disease Control and Prevention, 700 women die every year in the United States due to postpartum ...
by Colleen West, KOMO News Staff Seattle police are hoping the public can help identify the man who stole a $27,000 bracelet from Tiffany & Co. three weeks ago. (Photos via SPD) TOPICS ...
Mansfield High head girls basketball coach Brooke Brittain thanks Hannah Mathiesen for her support bracelet before their game against Lake Ridge in Mansfield, January 24, 2025. Hannah is the ...
We acknowledge Aboriginal and Torres Strait Islander peoples as the First Australians and Traditional Custodians of the lands where we live, learn and work.